
新形势下中西医结合医学的发展思考
Development Strategy of Chinese and Western Integrative Medicine Under New Circumstances
新型冠状病毒肺炎( COVID-19)疫情席卷全球,中西医结合医学作为我国特有的医学模式,在抗击疫情过程中发挥了重要作用;及时总结运用经验,提升中西医结合医学事业发展水平,将为我国全民健康与医药卫生事业发展提供坚实保障。本文利用文献分析、问卷调查等方法获得的基础数据,梳理了新中国成立以来中西医结合取得的基础成绩,总结了中西医结合医学在 COVID-19 疫情防控方面发挥的关键作用;在梳理发展现状的基础上,研判了中西医结合在医疗资源、临床教育科研、国际化等方面存在的不足。研究提出了实现中西医结合继承创新、引领世界传统医药与现代医学结合发展等我国新形势下中西医结合医学的建设目标;据此建议,完善中西医结合治理体系,加强中西医结合防治人才和队伍建设,积极推动中西医结合国际交流发展,弘扬中西医结合文化。
In 2020, the coronavirus disease (COVID-19) broke out and swept rapidly all over the world. The Chinese and western integrative medicine, a unique medical model in China, has played an important role in the fight against the epidemic. We need to draw experience from the fight against the epidemic to promote the development of Chinese and western integrative medicine and provide intellectual support and theoretical guarantee for the national health and medical undertakings. First, we review the achievements of the Chinese and western integrative medicine since 1949 using literature review and questionnaire survey, and summarize the key roles of this integrative medicine in the prevention and control of COVID-19. Subsequently, we analyze the weaknesses of the integrative medicine in terms of medical resources, clinical education and research, and internationalization, and propose the construction goals for this discipline under the new circumstances in China, including the inheritance and innovation of the Chinese and western integrative medicine and a world-leading role in the integration of Chinese traditional medicine with western medicine. Furthermore, we suggest that China should improve the governance system for the Chinese and western integrative medicine, enhance talent training in this discipline, actively promote international exchange, and encourage the Chinese and western medicine integration culture.
中西医结合医学 / 循证医学 / 评价体系 / 人才培养 / 新型冠状病毒肺炎
Chinese and western integrative medicine / evidence-based medicine / evaluation system / talent training / COVID-19
[1] |
马箭. 中西医汇通、中医科学化、中西医结合的历史研究 [D]. 哈 尔滨: 黑龙江中医药大学(博士学位论文), 2013. Ma J. Historic research on confluence of Chinese and western medicine, scientificalized Chinese medicine and integration of Chinese medicine and western medicine [D]. Haerbin: Heilongjiang University of Chinese Medicine(Doctoral dissertation), 2013.
|
[2] |
国家中医药管理局 . 中华人民共和国中医药法 [EB/ OL]. (2016-12-26)[2020-05-15]. http://fjs.satcm.gov.cn/ zhengcewenjian/2018-03-24/2249.html. National Administration of Traditional Chinese Medicine. Law of the People’s Republic of China on Traditional Chinese Medicine [EB/OL]. (2016-12-26)[2020-05-15]. http://fjs.satcm.gov.cn/ zhengcewenjian/2018-03-24/2249.html.
|
[3] |
李克强. 政府工作报告2018 [EB/OL]. (2018-03-05)[2020-05- 15]. http://www.gov.cn/zhuanti/2018lh/2018zfgzbg/2018zfbgdzs. htm#book7/page1. Li K Q. Government work report 2018 [EB/OL]. (2018-03-05) [2020-05-15]. http://www.gov.cn/zhuanti/2018lh/2018zfgzbg/2018 zfbgdzs.htm#book7/page1.
|
[4] |
《中国现代中药》编辑部. 传承精华 守正创新——热烈庆祝全国 中医药大会召开 [J]. 中国现代中药, 2019, 21(10): 2. Editorial Board of Modern Chinese Medicine. Inheriting essence and maintaining innovation: Warmly celebrating the National Conference of Traditional Chinese Medicine [J]. Modern Chinese Medicine, 2019, 21(10): 2.
|
[5] |
中华人民共和国国家卫生健康委员会. 中国–世界卫生组织新 型冠状病毒肺炎(COVID-19)联合考察报告 [EB/OL]. (2020-02- 29)[2020-05-15]. http://www.nhc.gov.cn/xcs/fkdt/202002/87fd925 10d094e4b9bad597608f5cc2c.shtml. National Health Commission of the People’s Republic of China. China-WHO novel coronavirus pneumonia (COVID-19) joint investigation report [EB/OL]. (2020-02-29)[2020-05-15]. http:// www.nhc.gov.cn/xcs/fkdt/202002/87fd92510d094e4b9bad597608 f5cc2c.shtml.
|
[6] |
Chan K W, Wong V T, Tang S C W. COVID-19: An update on the epidemiological, clinical, preventive and therapeutic evidence and guidelines of integrative Chinese–western medicine for the management of 2019 novel coronavirus disease [J]. The American Journal of Chinese Medicine, 2020, 48(3): 737–762.
|
[7] |
中华人民共和国国家卫生健康委员会. 2019年我国卫生健康 事业发展统计公报 [EB/OL]. (2020-06-06)[2020-05-15]. http:// www.nhc.gov.cn/guihuaxxs/s10748/202006/ebfe31f24cc145b198d d730603ec4442.shtml. National Health Commission of the People’s Republic of China. Statistical bulletin of health development 2019 [EB/OL]. (2020-06-06)[2020-05-15]. http://www.nhc.gov.cn/guihuaxxs/ s10748/202006/ebfe31f24cc145b198dd730603ec4442.shtml.
|
[8] |
杜建, 李爱花, 詹启敏, 等. 我国医药卫生人才培养战略研究 [J]. 中国工程科学, 2019, 21(2): 55–60. Du J, Li A H, Zhan Q M, et al. Strategic study on medical education and personnel training in China [J]. Straregic Study of CAE, 2019, 21(2): 55–60.
|
[9] |
毛静远, 毕颖斐, 张伯礼, 等. 对中西医结合发展战略的检视和 思考 [J]. 中国中西医结合杂志, 2019, 39(9): 1036–1038. Mao J Y, Bi Y F, Zhang B L, et al. The development strategy of integrated traditional Chinese and western medicine: A review [J]. Chinese Journal of Integrative Medicine, 2019, 39(9): 1036–1038.
|
[10] |
郑文科, 张俊华, 张伯礼, 等. 中医药防治新型冠状病毒感染的 肺炎各地诊疗方案综合分析 [J]. 中医杂志, 2020, 61(4): 277– 280. Zheng W K, Zhang J H , Zhang B L, et al. Comprehensive analysis of diagnosis and treatment schemes for prevention and treatment of novel coronavirus pneumonia by traditional Chinese medicine [J]. Journal of Traditional Chinese Medicine, 2020, 61(4): 277– 280.
|
[11] |
苗青, 丛晓东, 王冰, 等. 新型冠状病毒感染的肺炎的中医认识 与思考 [J]. 中医杂志, 2020, 61(4): 286–288. Miao Q, Cong X D, Wang B, et al. Understanding and thinking of novel coronavirus pneumonia in traditional Chinese medicine [J]. Journal of Traditional Chinese Medicine, 2020, 61(4): 286–288.
|
[12] |
于明坤, 柴倩云, 梁昌昊, 等. 新型冠状病毒肺炎中医预防及诊 疗方案汇总分析 [J]. 中医杂志, 2020, 61(5): 383–387. Yu M K, Chai Q Y, Liang C H, et al. An analyze of the traditional Chinese medicine prevention and treatment interventions for COVID-19 [J]. Journal of Traditional Chinese Medicine, 2020, 61(5): 383–387.
|
/
〈 |
|
〉 |